These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2915408)

  • 21. Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users.
    Brickner PW; Torres RA; Barnes M; Newman RG; Des Jarlais DC; Whalen DP; Rogers DE
    Ann Intern Med; 1989 May; 110(10):833-7. PubMed ID: 2653157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vertical transmission of HIV infection: descriptive epidemiology, risk factors and survival].
    Casabona Barbara J; Sánchez Ruiz E; Salas Ibáñez T; Curell Aguilá N; Fortuny Guasch C; Martí Gaudes C; Rodes Monegal A
    An Esp Pediatr; 1992 Nov; 37(5):367-71. PubMed ID: 1456617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of drug injection in the spread of HIV in Argentina and Brazil.
    Libonatti O; Lima E; Peruga A; González R; Zacarías F; Weissenbacher M
    Int J STD AIDS; 1993; 4(3):135-41. PubMed ID: 8324042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent developments in sexually transmitted diseases: is heterosexual transmission of human immunodeficiency virus a major epidemiologic factor in the spread of acquired immunodeficiency syndrome? II: The United States and western Europe.
    Felman YM
    Cutis; 1990 Aug; 46(2):114, 116-7. PubMed ID: 2209074
    [No Abstract]   [Full Text] [Related]  

  • 25. HIV infection among women entering the New York State correctional system.
    Smith PF; Mikl J; Truman BI; Lessner L; Lehman JS; Stevens RW; Lord EA; Broaddus RK; Morse DL
    Am J Public Health; 1991 May; 81 Suppl(Suppl):35-40. PubMed ID: 2014882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of HIV-1 infection among injection drug users in Montreal, 1985-1987.
    Lamothe F; Bruneau J; Soto J; Brabant M; Vincelette J
    Can Dis Wkly Rep; 1988 Dec; 14(50):225-7. PubMed ID: 3242908
    [No Abstract]   [Full Text] [Related]  

  • 27. The changing pattern of human immunodeficiency virus type 1 infection in intravenous drug users. Results of a six-year seroprevalence study in Palermo, Italy.
    Romano N; Vitale F; Alesi DR; Bonura F; La Licata R; Intonazzo V; Dardanoni G; Mammina C
    Am J Epidemiol; 1992 Jun; 135(11):1189-96. PubMed ID: 1626537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of human immunodeficiency virus infection and acquired immunodeficiency syndrome.
    Berkelman RL; Heyward WL; Stehr-Green JK; Curran JW
    Am J Med; 1989 Jun; 86(6 Pt 2):761-70. PubMed ID: 2658580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS and the new drug injector.
    Friedman SR; Des Jarlais DC; Neaigus A; Abdul-Quader A; Sotheran JL; Sufian M; Tross S; Goldsmith D
    Nature; 1989 Jun; 339(6223):333-4. PubMed ID: 2725656
    [No Abstract]   [Full Text] [Related]  

  • 30. The AIDS epidemic in New York City, 1981-1984. New York City Department of Health AIDS Surveillance.
    Am J Epidemiol; 1986 Jun; 123(6):1013-25. PubMed ID: 3706272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behaviour change and stabilization of seroprevalence levels in communities of injecting drug users: correlation or causation?
    Blower S
    J Acquir Immune Defic Syndr (1988); 1991; 4(9):920-3. PubMed ID: 1895214
    [No Abstract]   [Full Text] [Related]  

  • 32. Death, AIDS morbidity, and HIV seroprevalence in New York City intravenous drug abusers.
    Burkett W; Brown LS
    J Natl Med Assoc; 1990 Nov; 82(11):777-80. PubMed ID: 2258951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus infection in a cohort of intravenous drug users in New York City. Demographic, behavioral, and clinical features.
    Brown LS; Chu A; Nemoto T; Ajuluchukwu D; Primm BJ
    N Y State J Med; 1989 Sep; 89(9):506-10. PubMed ID: 2797531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence rate of acquired immunodeficiency syndrome in selected populations.
    Hardy AM; Allen JR; Morgan WM; Curran JW
    JAMA; 1985 Jan; 253(2):215-20. PubMed ID: 3965772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users.
    Selwyn PA; Carter RJ; Schoenbaum EE; Robertson VJ; Klein RS; Rogers MF
    JAMA; 1989 Jun 23-30; 261(24):3567-71. PubMed ID: 2724503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV infection among intravenous drug abusers in the United States and Europe.
    Haverkos HW
    NIDA Res Monogr; 1988; 80():7-17. PubMed ID: 3136347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The acquired immunodeficiency syndrome and intravenous drug abuse.
    Battjes RJ; Leukefeld CG; Pickens RW; Haverkos HW
    Bull Narc; 1988; 40(1):21-34. PubMed ID: 3064841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
    Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
    CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous drug abuse speeds the spread of AIDS.
    Netw Res Triangle Park N C; 1988; 10(2):4-5. PubMed ID: 12342120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating population prevalence of human immunodeficiency virus infection in urban areas with high rates of intravenous drug use: a model of the Bronx in 1988.
    Drucker E; Vermund SH
    Am J Epidemiol; 1989 Jul; 130(1):133-42. PubMed ID: 2787104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.